(Q36721990)

15 August 2017

Is etoricoxib effective in preventing heterotopic ossification after primary total hip arthroplasty? (English)

1 reference

15 August 2017

Jaap J Brunnekreef

1

1 reference

15 August 2017

Paul Hoogervorst

2

1 reference

15 August 2017

Marieke J Ploegmakers

3

1 reference

15 August 2017

Wim H Rijnen

4

1 reference

15 August 2017

Berend W Schreurs

5

1 reference

15 August 2017

29 January 2013

1 reference

International Orthopaedics

15 August 2017

1 reference

15 August 2017

37

1 reference

15 August 2017

4

1 reference

15 August 2017

583-587

1 reference

https://scigraph.springernature.com/pub.10.1007/s00264-013-1781-0

15 August 2017

0 references

cites work

Preoperative administration of etoricoxib in patients undergoing hip replacement causes inhibition of inflammatory mediators and pain relief

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609973

Selective COX-2 inhibitor versus nonselective COX-1 and COX-2 inhibitor in the prevention of heterotopic ossification after total hip arthroplasty: a meta-analysis of randomised trials.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609973

Is radiation superior to indomethacin to prevent heterotopic ossification in acetabular fractures?: a systematic review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609973

Pharmacological treatment of heterotopic ossification following hip and acetabular surgery

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609973

Heterotopic ossification: Pathophysiology, clinical features, and the role of radiotherapy for prophylaxis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609973

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609973

Non-steroidal anti-inflammatory drugs for preventing heterotopic bone formation after hip arthroplasty

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609973

Selective COX-2 inhibition and cardiovascular effects: a review of the rofecoxib development program

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609973

Incidence of heterotopic bone formation after major hip surgery

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609973

A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609973

Ectopic ossification following total hip replacement. Incidence and a method of classification

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609973

Optimal two-stage designs for phase II clinical trials

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609973

COX 2 selectivity of non-steroidal anti-inflammatory drugs and perioperative blood loss in hip surgery. A randomized comparison of indomethacin and meloxicam.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609973

The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609973

Heterotopic ossification prophylaxis with indomethacin increases the risk of long-bone nonunion.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609973

Indomethacin for 3 days is not effective as prophylaxis for heterotopic ossification after primary total hip arthroplasty

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3609973

The use of radiation to discourage ectopic bone. A nine-year study in surgery about the hip

5 September 2018

1 reference

12 December 2020

Indomethacin for the prevention of heterotopic ossification following total hip arthroplasty. Effectiveness, contraindications, and adverse effects

1 reference

12 December 2020

1 reference

12 December 2020

Rofecoxib inhibits heterotopic ossification after total hip arthroplasty

1 reference

12 December 2020

10.1007/S00264-013-1781-0

Identifiers

DOI

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

23359100

1 reference